Aspen Aerogels (NYSE:ASPN) Issues Q2 2026 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of -0.240–0.17 for the period, compared to the consensus estimate of -0.210. The company issued revenue guidance of $40.0 million-$48.0 million, compared to the consensus revenue estimate of $41.1 million.

Aspen Aerogels Stock Down 1.4%

Shares of ASPN traded down $0.07 during mid-day trading on Friday, reaching $5.05. The company’s stock had a trading volume of 2,011,581 shares, compared to its average volume of 1,599,219. The company has a market cap of $418.02 million, a price-to-earnings ratio of -1.06 and a beta of 2.83. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.78. The company has a quick ratio of 3.29, a current ratio of 3.90 and a debt-to-equity ratio of 0.34. The business has a fifty day moving average of $3.46 and a 200 day moving average of $3.79.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $37.88 million for the quarter, compared to analyst estimates of $36.58 million. Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The company’s revenue was down 51.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.06) earnings per share. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, analysts forecast that Aspen Aerogels will post -0.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Barclays cut their price objective on Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating for the company in a report on Thursday, March 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Friday, March 27th. Roth Mkm reaffirmed a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a research report on Friday. Finally, TD Cowen cut their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Aspen Aerogels presently has an average rating of “Hold” and a consensus price target of $4.94.

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently modified their holdings of the company. Raymond James Financial Inc. raised its holdings in Aspen Aerogels by 6.8% in the 2nd quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after acquiring an additional 1,687 shares during the period. Legal & General Group Plc increased its position in shares of Aspen Aerogels by 3.6% during the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock valued at $397,000 after purchasing an additional 2,324 shares during the period. Osaic Holdings Inc. raised its stake in shares of Aspen Aerogels by 29.1% in the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock valued at $63,000 after buying an additional 2,390 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Aspen Aerogels by 12.1% in the second quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock worth $146,000 after purchasing an additional 2,656 shares in the last quarter. Finally, Deutsche Bank AG raised its holdings in shares of Aspen Aerogels by 1.3% in the 4th quarter. Deutsche Bank AG now owns 223,093 shares of the construction company’s stock worth $631,000 after buying an additional 2,880 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.